No Data
Guangdong Transtek Medical Electronics (300562.SZ) announced an expected increase, with an annual net income projected to be between 60 million yuan and 64 million yuan, a year-on-year increase of 74.58% to 86.22%.
Guangdong Transtek Medical Electronics (300562.SZ) disclosed the performance forecast for 2024, and the company expects to belong to the Shareholder...
Happy Healthcare: 2024 Annual Results Forecast
Investors Met With Slowing Returns on Capital At Guangdong Transtek Medical Electronics (SZSE:300562)
On January 8, A-share investment precautions︱*ST Renda: Stocks may be delisted; Jinzi Ham Co., Ltd.: Shareholder Shi Yanjun plans to reduce his shareholding by no more than 1.3%.
Guangdong Transtek Medical Electronics' controlling shareholder Pan Weichao plans to reduce his shareholding by no more than 2.46%; one of the actual controllers of Senba Sensing Technology plans to reduce their combined shareholding by no more than 2.73%; the major shareholder of Senba Sensing Technology, Yingbei Investment, plans to reduce their shareholding by no more than 2%; Jinzi Ham Co., Ltd. shareholder Shi Yanjun plans to reduce his shareholding by no more than 1.3%; Shenzhen Hopewind Electric's Datacenter related Business is still in the early verification stage; *ST Special Treat Stocks may be suspended from listing.
Guangdong Transtek Medical Electronics (300562.SZ): The controlling shareholder Pan Weichao plans to reduce his Shareholding by no more than 2.46%.
On January 7, Gelonghui reported that Mr. Pan Weichao, the company's controlling shareholder, actual controller, Director, and senior management personnel, who Holds 72,066,874 shares of Guangdong Transtek Medical Electronics (accounting for 33.28% of the total shares, with the "total shares" being the amount after excluding shares held in the company's repurchase special account), plans to reduce his shareholding through centralized bidding and block trading within three months after 15 trading days from the date of this announcement (February 6, 2025), with a total intended reduction not exceeding 5,327,228 shares, accounting for the company's total shares.
Guangdong Transtek Medical Electronics (300562.SZ): Accelerate the commercial application of digital chronic disease services, achieving the "second growth curve" through "device + AI Software + Medical Services."
Gelonghui, on December 27, announced that Guangdong Transtek Medical Electronics (300562.SZ) stated during an investor relations event that, first, in terms of business development: the company will actively enhance the comprehensive competitiveness of its products through research and development innovation, by developing potential needs of existing customers and further exploring new customers and new demands to increase market share overseas. At the same time, it will provide Asia Vets health monitoring products for domestic and international well-known health monitoring device industry clients to further open up the domestic market. Secondly, in terms of product innovation: the company will continue to increase its investment in research and development for digital chronic disease management, achieve product innovation and technological innovation, and launch new products. The company will promote its smart health...
It's Down 30% But Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Could Be Riskier Than It Looks